AtomVie Global Radiopharma is a CDMO specializing in the manufacturing and distribution of clinical and commercial radiopharmaceuticals. It offers scientific, technical, regulatory, quality, logistics, and business expertise for the development of radiotherapeutics from Phase 1 to the commercial marketplace. AtomVie is a spinout from the Centre for Probe Development and Commercialization and has a purpose-built facility that will be operational in 2024. For more information, visit their website or contact info@atomvie.com.